Davis Corley, CEO of Neurolens, outlines the importance a new study that show statistically significant improvement of headaches with the use of Neurolens.
Davis Corley
Advertisement
Articles by Davis Corley
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Optometry Times - Clinical News & Expert Optometrist Insights
1
Noninvasive LED light therapy shows long-term safety in early cataract follow-up
2
FDA approves Yuvezzi (carbachol and brimonidine tartrate ophthalmic solution) 2.75%/0.1% for presbyopia
3
PRIMA retinal implant found to restore vision in patients with advanced GA
4
When Mites Meet Their Match: Empowering Patients With Targeted Treatment for Demodex Blepharitis
5